General psychiatry, consultation-liaison psychiatry, and adult psychiatric practice guide his work as a general psychiatry expert witness with more than 30 years of experience in the medical field. He has experience in basic neuroscience, psychopharmacology, cognitive behavioral psychotherapy, medication interactions, and medication side effects. He has also provided consultations, deposition testimony, and courtroom testimony for more than 20 years as a general psychiatry expert witness. His clinical background includes adult psychiatry, psychiatric emergency services, geriatric psychiatry, consultation-liaison psychiatry, psychosomatic medicine, medical ethics, and psychiatric treatment in private practice.

He earned an M.D. and an undergraduate degree with highest honors in biochemistry, participated in graduate medical training in molecular genetics, and completed internship, residency, and fellowship training in psychiatry, consultation-liaison psychiatry, and medical ethics. He is licensed as a physician and surgeon, holds controlled substances and Drug Enforcement Administration registrations, and is a Diplomate in Psychiatry through the American Board of Psychiatry and Neurology. His professional association involvement includes the American Psychiatric Association and the Utah Psychiatric Association, and his committee experience includes ethics, credentials, and residency evaluation service.

His professional experience includes private practice in adult psychiatry, director-level responsibility for consultation-liaison psychiatry, psychiatric emergency services, extended rehabilitation services, and geriatric psychiatry programs. He has held clinical assistant professor-level responsibilities and consulting medical staff experience in neuropsychiatric care. His teaching background includes psychosomatic medicine, consultation psychiatry, electroconvulsive therapy supervision, psychotherapy supervision, medical ethics, and grand rounds presentations involving neurotransmitter receptors, Alzheimer’s pharmacotherapy, Parkinson’s psychosis, and benzodiazepine abuse.